The Ethos Podcast - What is the point of having company signatories?

Ethos Podcast: Do Companies Still Need Signatories in Pharma Compliance? This episode of the Ethos Pharmaceutical Ethics & Compliance Podcast explores a key question in the pharmaceutical industry: What is the point of having company signatories in today’s compliance landscape? With compliance reviews increasingly outsourced to specialist agencies and AI-powered tools becoming more common, we ask whether in-house expertise is still essential. Hosted by Dr Nick Broughton with guests Dr Ravi Pawa and Dr Sheuli Porkess, this discussion covers: The business case for maintaining in-house expertise Why accountability matters in compliance decisions The limitations of AI in compliance and ethics How effective oversight depends on subject-matter knowledge This is a must-listen for anyone working in: Pharmaceutical compliance Ethics and regulation ABPI code of practice AI and compliance technologies 🔗 Watch the full discussion and subscribe for future episodes on pharmaceutical ethics, compliance best practices, and the evolving role of signatories in the life sciences industry.